09/10/2007 - 09:12

pSivida opens enrolments for macular edema treatment trials

09/10/2007 - 09:12

Bookmark

Save articles for future reference.

Perth-based biotechnology company pSivida Ltd has completed enrolment for the first studies of absorption, distribution and metabolism of its diabetic macular edema treatment Medidur, the company has announced.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options